Evaluation of urinary bladder cancer antigen as a marker for diagnosis of transitional cell carcinoma of the urinary bladder

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 60, Issue 4, 2000, Pages 275-282

  Heicappell, R ^a   Schostak, M ^a   Muller, M ^a   Miller, K ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Biological; Carcinoma; Diagnosis; Transitional cell; Tumor markers

Indexed keywords

CYTOKERATIN 18; TUMOR ANTIGEN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; URINE LEVEL;

EID: 0033866503     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655100750046431     Document Type: Article

References (34)

1. Cancer incidence and mortality in the European Union: Cancer registry data and estimates of national incidence for 1990
2. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence
3. Flow cytometry versus urinary cytology in the evaluation of patients with bladder cancer
4. Low-grade transitional cell carcinoma of the urinary bladder: Application of select cytologic criteria to improve diagnostic accuracy
5. Flow cytometry of low stage bladder tumors: Correlation with cytologic and cystoscopic diagnosis
6. Importance of urinary cytology and future role of flow cytometry
7. Prognostic indices in transitional cell carcinoma of the bladder
8. Superficial bladder cancer: Progression and recurrence
9. Cytokeratin polypeptide patterns of different epithelia of the human male urogenital tract: Immunofluorescence and gel electrophoretic studies
10. Tissue polypeptide antigen (TPA), some cytokeratins and epithelial membrane antigen (EMA) in normal, inflamed and malignant urothelium
11. Flow cytometric demonstration of shared antigens between human bladder cancer cells and normal host macrophages
12. Tissue-specific markers in flow cytometry of urological cancers: Cytokeratins in bladder carcinoma
13. Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression
14. Cytokeratin expression patterns in metastatic transitional cell carcinoma of the urinary tract. An immunohistochemical study comparing local tumor and autologous metastases
15. The altered expression of cytokeratin polypeptides in carcinomas of human bladder
16. TNM classification of malignant tumours
17. Initial evaluation of the bladder tumor antigen test in superficial bladder cancer
18. Urinary nuclear matrix protein as a marker for transitional cell carcinoma of the urinary tract
19. Quantitative detection of human complement factor H-related protein in transitional cell carcinoma of the urinary bladder
20. Cytokeratins in normal and malignant transitional epithelium Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines
21. Cytokeratin 14 as a marker of squamous differentiation in transitional cell carcinomas
22. Immunohistochemical localization of cytokeratin 17 in transitional cell carcinomas of the human urinary tract
23. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma
24. Cytokeratin 20: A new marker for early detection of bladder cell carcinoma?
25. Schistosomiasis associated bladder carcinoma expression of cytokeratin
26. Immunohistochemical markers defined by monoclonal antibodies and response to bacillus Calmette-Guerin endovesical immunotherapy for superficial bladder tumors
27. Initial evaluation of CYFRA 21-1 diagnostic performances as a urinary marker in bladder transitional cell carcinoma
28. Clinical evaluation of soluble cytokeratin 19 fragments (CYFRA 21-1) in serum and urine of patients with bladder cancer
29. Cytokeratin expression during neoplastic progression of human transitional cell carcinomas as detected by a monoclonal and a polyclonal antibody
30. Cytokeratin pattern in normal and pathological bladder urothelium: Immunohistochemical investigation using monoclonal antibodies
31. Flow cytometry study of cytokeratin 18 expression according to tumor grade and deoxyribonucleic acid content in human bladder tumors
32. Cytokeratin shedding in urine: A biological marker for bladder cancer?
33. Quantitative analysis of keratin 18 in the urine of patients with bladder cancer
34. Initial evaluation of the new urinary bladder cancer rapid test in the detection of transitional cell carcinoma of the bladder